Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Postoperative Nausea and Vomiting
Conditions
Postoperative Nausea and Vomiting
Trial Timeline
Jul 1, 2008 → Aug 1, 2010
NCT ID
NCT00738621About Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, Placebo
Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, Placebo is a approved stage product being developed by Merck for Postoperative Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT00738621. Target conditions include Postoperative Nausea and Vomiting.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00738621 | Approved | Completed |
Competing Products
20 competing products in Postoperative Nausea and Vomiting